Jean Marc Extra

Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer

Guy Meyer, Zora Marjanovic, Judith Valcke et al. · Archives of Internal Medicine · 2002 · 798 citations

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.

Philippe Rougier, R. Bugat, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 1997 · 429 citations

Phase I study of oxaliplatin in patients with advanced cancer

Jean Marc Extra, Marc Espié, Fabien Calvo et al. · Cancer Chemotherapy and Pharmacology · 1990 · 338 citations

Advanced Cancer, Medicine, Cancer Management +6

Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion.

Jean Marc Extra, Frédérique Rousseau, René Bruno et al. · PubMed · 1993 · 253 citations

Chemoprevention Strategy, Pharmacokinetic Study, Pharmacotherapy +21

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials

G G Chabot, D Abigerges, G. Catimel et al. · Annals of Oncology · 1995 · 172 citations

Pharmacological Study, Medicine, Active Metabolite Sn-38 +5